慢性肾脏病中中心动脉压与心血管结局
在慢性肾功能不全队列(n=2875)中,中位随访5.5年,比较中心动脉压与肱动脉压对心血管结局的预测价值。结果显示两者最高四分位均与复合心血管结局风险升高相关,但中心动脉压测量并未比肱动脉压更好地预测心血管结局或死亡。
要点
- 肱动脉收缩压最高四分位(≥138 mmHg)与复合心血管结局风险升高相关(HR 1.59)。
- 中心动脉收缩压最高四分位同样与复合心血管结局风险升高相关(HR 1.69)。
- 中心动脉压测量未改善对心血管结局或死亡的预测能力。
核心结论
- 在CKD患者中,肱动脉压和中心动脉压升高均与心血管疾病结局风险升高相关。
- 与肱动脉压测量相比,中心动脉压测量并未提高预测心血管疾病结局或死亡的能力。
研究设计与样本
- 前瞻性纵向研究(慢性肾功能不全队列),纳入2875例CKD患者,使用SphygmoCorPVx系统测量中心动脉压。
- 采用Cox比例风险模型分析,平均年龄60岁,中位随访5.5年。
主要发现
- 肱动脉收缩压最高四分位(≥138 mmHg)与复合心血管结局风险升高相关(HR 1.59;95%CI 1.17-2.17;c统计量0.76),但与全因死亡无关(HR 1.28;95%CI 0.90-1.80)。
- 中心动脉收缩压最高四分位与复合心血管结局风险升高相关(HR 1.69;95%CI 1.24-2.31;c统计量0.76)。
临床怎么用
- 在CKD患者中,中心动脉压测量未显示优于肱动脉压的预测价值,肱动脉压测量仍可作为风险评估的常规手段。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Central BP measurements provide noninvasive measurement of aortic BP; our objectives were to examine the association of central and brachial BP measurements with risk of cardiovascular outcomes and mortality in patients with CKD and to determine the role of central BP measurement in conjunction with brachial BP in estimating cardiovascular risk. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In a prospective, longitudinal study (the Chronic Renal Insufficiency Cohort), central BP was measured in participants with CKD using the SphygmoCorPVx System. Cox proportional hazards models were used for analyses. RESULTS: Mean age of the participants (n=2875) was 60 years old. After a median follow-up of 5.5 years, participants in the highest quartile of brachial systolic BP (≥138 mm Hg) were at higher risk for the composite cardiovascular outcome (hazard ratio, 1.59; 95% confidence interval, 1.17 to 2.17; c statistic, 0.76) but not all-cause mortality (hazard ratio, 1.28; 95% confidence interval, 0.90 to 1.80) compared with those in the lowest quartile. Participants in the highest quartile of central systolic BP were also at higher risk for the composite cardiovascular outcome (hazard ratio, 1.69; 95% confidence interval, 1.24 to 2.31; c statistic, 0.76) compared with participants in the lowest quartile. CONCLUSIONS: We show that elevated brachial and central BP measurements are both associated with higher risk of cardiovascular disease outcomes in patients with CKD. Measurement of central BP does not improve the ability to predict cardiovascular disease outcomes or mortality in patients with CKD compared with brachial BP measurement.
引用
- Rahman M, Hsu JY, Desai N, et al. Central Blood Pressure and Cardiovascular Outcomes in Chronic Kidney Disease. Clin J Am Soc Nephrol. 2018. PMID: 29475992. doi:10.2215/CJN.08620817
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。